Hält derzeit eine Position bei Momenta Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Treasurer | Momenta Pharmaceuticals Inc | 1. Oktober 2018 - |
Chief Financial Officer, Treasurer | Momenta Pharmaceuticals Inc | 1. Oktober 2018 - 8. Januar 2020 |
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Momenta Pharmaceuticals Inc | 1. Mai 2017 - 1. Oktober 2018 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-15 | 2023-05-11 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
949
-0.9%
9,879.369 USD |
949 -0.9% | 9,87 | 9.369 USD | |
2023-03-06 | 2023-03-03 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
184
-0.2%
8,891.636 USD |
184 -0.2% | 8,89 | 1.636 USD | |
2023-02-15 | 2023-02-13 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
4.287
-5.3%
9,6741.435 USD |
4.287 -5.3% | 9,67 | 41.435 USD | |
2022-12-06 | 2022-12-05 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
193
-0.2%
10,231.974 USD |
193 -0.2% | 10,23 | 1.974 USD | |
2022-09-08 | 2022-09-06 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
192
-0.2%
15,012.882 USD |
192 -0.2% | 15,01 | 2.882 USD | |
2022-06-06 | 2022-06-03 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
1.527
-1.8%
11,5417.617 USD |
1.527 -1.8% | 11,54 | 17.617 USD | |
2022-03-07 | 2022-03-03 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
767
-0.9%
17,3313.290 USD |
767 -0.9% | 17,33 | 13.290 USD | |
2022-01-13 | 2022-01-11 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
1.744
-5.3%
25,7044.821 USD |
1.744 -5.3% | 25,70 | 44.821 USD | |
2021-01-13 | 2021-01-12 |
Editas Medicine Inc
(EDIT)
|
V Verkauf |
1.568
-7.8%
78,27122.727 USD |
1.568 -7.8% | 78,27 | 122.727 USD | |
2019-10-29 | 2019-10-25 |
Momenta Pharmaceuticals Inc
(MNTA)
|
GV Geplanter Verkauf |
6.802
-50.0%
15,00102.030 USD |
6.802 -50.0% | 15,00 | 102.030 USD | |
2019-10-21 | 2019-10-18 |
Momenta Pharmaceuticals Inc
(MNTA)
|
GV Geplanter Verkauf |
2.936
-17.7%
13,8340.605 USD |
2.936 -17.7% | 13,83 | 40.605 USD | |
2019-02-19 | 2019-02-14 |
Momenta Pharmaceuticals Inc
(MNTA)
|
GV Geplanter Verkauf |
703
-5.7%
13,109.209 USD |
703 -5.7% | 13,10 | 9.209 USD | |
2019-02-14 | 2019-02-13 |
Momenta Pharmaceuticals Inc
(MNTA)
|
GV Geplanter Verkauf |
1.410
-10.3%
12,7017.907 USD |
1.410 -10.3% | 12,70 | 17.907 USD |